12584 Montellano Ter, San Diego, CA 92130 • 6193842289
3937 Camino Lindo, San Diego, CA 92122 • 8586239506
Allentown, PA
Cambridge, MA
Honolulu, HI
200 Mountain Ave, Malden, MA 02148 • 7813882644
Work
Company:
Pfizer
Jan 2007 to Aug 2018
Position:
Associate research fellow
Skills
Drug Discovery • Drug Development • Protein Chemistry • Medicinal Chemistry • Protein Purification • Pharmaceutical Industry • Molecular Biology • Clinical Development • Biochemistry • Drug Design • Assay Development • Cell Biology • Life Sciences
Alexei Brooun - San Diego CA, US Oleg Brodsky - San Diego CA, US Ellen Chien - La Jolla CA, US Douglas R. Dougan - Calgary, CA Clifford D. Mol - San Diego CA, US Gyorgy Snell - Richmond CA, US
Assignee:
Takeda San Diego, Inc. - San Diego CA
International Classification:
C07K 14/00
US Classification:
530350
Abstract:
Provided are crystals relating to human Glucocorticoid Receptor and its various uses.
Alexei Brooun - San Diego CA, US David J. Hosfield - San Diego CA, US Robert J. Skene - San Diego CA, US Leslie W. Tari - San Diego CA, US Sheng Ye - Allen TX, US
Assignee:
Takeda San Diego, Inc. - San Diego CA
International Classification:
C12Q 1/00 C12N 9/88
US Classification:
435 4, 435232
Abstract:
Provided are crystals relating to MvaS (HMG-CoA Synthase) and its various uses.
Alexei Brooun - San Diego CA, US Ellen Y. T. Chien - La Jolla CA, US Douglas R. Dougan - Calgary, CA Andrew J. Jennings - La Jolla CA, US Michelle L. Kraus - Temecula CA, US Clifford D. Mol - San Diego CA, US
Assignee:
Takeda San Diego, Inc. - San Diego CA
International Classification:
C12N 9/12
US Classification:
435194
Abstract:
Provided are crystals relating to Protein kinase Bα/AKT1 and its various uses.
Crystallization Of The Catalytic Domain Of Human Phosphodiesterase 4-D3 (Pde4-D3)
Alexei Brooun - San Diego CA, US Ellen Chien - La Jolla CA, US Douglas R. Dougan - Calgary, CA Michelle L. Kraus - Temecula CA, US Clifford D. Mol - San Diego CA, US Gyorgy Snell - Richmond CA, US
Assignee:
Takeda San Diego, Inc. - San Diego CA
International Classification:
C12N 9/16 C12N 9/00
US Classification:
435196, 435183, 436 4
Abstract:
Provided are crystals relating to human phosphodiesterase 4-D3 (PDE4-D3), methods for forming crystals comprising PDE4-D3 and crystals comprising PDE4-D3 co-crystallized with a ligand molecule, and methods of using crystals comprising PDE4-D3.
Crystalline Composition Of Farsenyl Pyrophosphate Synthase (Ispa)
Peter Kuhn - Solana Beach CA, US Anand Kolatkar - San Diego CA, US Alexei Brooun - San Diego CA, US Jill Chrencik - San Diego CA, US Michelle Kraus - Temecula CA, US
The invention relates to the three-dimensional structure of a crystal of an EphB4 receptor complexed with a ligand. The three-dimensional structure of a Receptor-Ligand Complex is disclosed. The receptor-ligand crystal structure, wherein the ligand is an inhibitor molecule, is useful for providing structural information that may be integrated into drug screening and drug design processes. Thus, the invention also relates to methods for utilizing the crystal structure of the Receptor-Ligand Complex for identifying, designing, selecting, or testing inhibitors of the EphB4 receptor protein, such inhibitors being useful as therapeutics for the treatment or modulation of i) diseases; ii) disease symptoms; or iii) the effect of other physiological events mediated by the receptor.
Crystal Of A Receptor-Ligand Complex And Methods Of Use
Peter Kuhn - Solana Beach CA, US Alexei Brooun - San Diego CA, US Jill Chrencik - San Diego CA, US Michelle Kraus - Temecula CA, US
Assignee:
The Scripps Research Institute - La Jolla CA
International Classification:
G01N 33/00 C07K 1/00 G06G 7/48
US Classification:
435007920, 530350000, 703011000
Abstract:
The invention relates to the three-dimensional structure of a crystal of an EphB4 receptor complexed with a ligand. The three-dimensional structure of a Receptor-Ligand Complex is disclosed. The receptor-ligand crystal structure, wherein the ligand is an inhibitor molecule, is useful for providing structural information that may be integrated into drug screening and drug design processes. Thus, the invention also relates to methods for utilizing the crystal structure of the Receptor-Ligand Complex for identifying, designing, selecting, or testing inhibitors of the EphB4 receptor protein, such inhibitors being useful as therapeutics for the treatment or modulation of i) diseases; ii) disease symptoms; or iii) the effect of other physiological events mediated by the receptor.
Alexei Brooun - San Diego CA, US David J. Hosfield - San Diego CA, US Robert J. Skene - San Diego CA, US Leslie W. Tari - San Diego CA, US Sheng Ye - Allen TX, US
Assignee:
Takeda San Diego, Inc. - San Diego CA
International Classification:
G01N 33/48 G06G 19/00
US Classification:
702 19, 703 11
Abstract:
Provided are structure coordinates relating to MvaS and its various uses.
Pfizer Jan 2007 - Aug 2018
Associate Research Fellow
Merck Jan 2007 - Aug 2018
Director, Target Protein Design
The Scripps Research Institute Jun 2004 - Dec 2006
Scientific Associate
Syrrx Jan 2001 - Jan 2004
Senior Scientist
Skills:
Drug Discovery Drug Development Protein Chemistry Medicinal Chemistry Protein Purification Pharmaceutical Industry Molecular Biology Clinical Development Biochemistry Drug Design Assay Development Cell Biology Life Sciences
Youtube
2017 Distinguished Alumnus - Alexei V. Filipp...
Alexei V. Filippenko,(PhD '84, Astronomy) Professor of Astronomy, UC B...
Duration:
17m 34s
FULL MATCH | Alexis Lebrun vs Dimitrij Ovtcha...
Watch the FULL match replay of Alexis Lebrun vs Dimitrij Ovtcharov in ...
Duration:
28m 30s
Them Skates presents : ALEX BROSKOW | Skatin...
ALEX BROSKOW By Gregory Preston Themskates.com.
Duration:
3m 12s
Book Talk | Russian Grand Strategy in the Era...
Is the Russian leadership acting strategically or opportunisticall... ...
Duration:
58m 58s
What I Shoot with in 2023 // Camera Gear
Wanted to share what I use to shoot with and why - since I love watchi...
Duration:
9m 24s
Enzymes That Are Not Proteins: The Discovery ...
HHMI President Dr. Thomas Cech discussing his Nobel Prize-winning disc...